GEN News Highlights: Oct 17, 2011 Roche is to buy hepatitis C therapeutics firm Anadys Pharmaceuticals in a cash deal worth a total of $230 million. Roche says it will immediately initiate a tender offer to buy all the outstanding shares of Anadys’ common stock at $3.70 per share, which represents a 256% premium to the latter’s closing price as the markets closed before the weekend. Anadys’ directors and management have already agreed to tender their shares, which amount to about 7.9% of the firm.
By KRISTEN WYATT, Associated Press – Wed Jan 19, 4:31 pm ET DENVER – Some Colorado lawmakers say their state should be the first one where people become organ donors by default, even though other states' efforts have been halted by worries about making such a personal decision automatic.
By Kelly Luker There could be worse things than having a chronic, life-threatening, stigmatizing virus. No, really.
This is not the beginning of a tell-all memoir, but merely a bit of history that is relevant to a here-and-now situation that found its roots in that decade.
Transplant Physician: Name Goes Here
Contact Info Goes Here
Traditional Chinese Medicine: Name Goes Here
Contact Info Goes Here
Gastroenterology: Name Goes Here
Contact Info Goes Here
Talk about the doctors here.
Building a team to make life easier during treatment, and finally, wellness!
As patients, we need all the help we can get when undergoing Interferon/Ribavirin therapy. It is important to use all the tools we have at our disposal to give us the best chance for recovery.MORE >>
New York City's Center for the Study of Hepatitis C, established in 2000 at The Rockefeller University, Weill Medical College of Cornell University and New York- Presbyterian Hospital, is the only comprehensive, multidisciplinary center dedicated to the study of HCV and hepatic disease in the tri-state area.
Initial funding was provided by the Greenberg Medical Research Institute.
Ongoing research depends heavily on grant support from the National Institutes of Health and private donations.MORE >>
The transplant hepatology fellowship at The Mount Sinai Medical Center in New York City offers year-long advanced clinical training to applicants who have already completed a gastroenterology fellowship.
Mount Sinai's transplant hepatology fellowship was the first to be ACGME-approved in the Northeast and remains the largest such fellowship in the United States.
The program was reaccredited in 2010 by ACGME for the maximum five-and-a-half years. MORE >>
Hepatitis C Resources
Let Billy Drop guide you while exploring the Hepatitis Community experience.
Information for health care professionals:
The American Liver Foundation is committed to supporting progress in liver disease treatment and assisting those who work in the field of hepatology. Whether you are a researcher pursuing a liver-related project or a physician seeking materials for your patients, we can help. MORE >> Then click here for webmaster.
Buy a shirt, a hat, a sticker or a dvd to help us keep you informed.